Bio-Path stockholders approve 2022 Stock Incentive Plan, elect five directors

BIO-PATH HOLDINGS, INC.

Approved 2022 Stock Incentive Plan authorizing up to 1,300,000 shares for equity awards.
Re-elected directors: Peter H. Nielsen, Heath W. Cleaver, Paul D. Aubert, Aline Sherwood, Douglas P. Morris.
Advisory vote on executive compensation approved (2,076,879 for, 237,410 against).
Ratified Ernst & Young as independent auditor for fiscal 2022 (3,920,967 for, 300,923 against).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-PATH HOLDINGS, INC. shareholders approved Non-binding advisory approval of the compensation of the Company’s named executive officers.

Proposal: say on pay
Outcome: passed

Exact text from the filing

Proposal 3 : For the non-binding advisory approval of the compensation of the Company’s named executive officers: Shares Voted “For” Shares Voted “Against” Shares Abstained Broker Non- Votes 2,076,879 237,410 25,588 1,937,120

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-PATH HOLDINGS, INC. shareholders approved Election of Directors.

Proposal: director election
Outcome: passed

Exact text from the filing

Proposal 1 : For the election of directors of the Company, to hold office until the Company’s next annual meeting of stockholders or until their respective successors have been duly elected and qualified: Name of Nominee Shares Voted “For” Shares Voted “Against” Shares Withheld Shares Abstained Broker Non- Votes Peter H. Nielsen 2,154,714 -- 185,163 -- 1,937,120 Heath W. Cleaver 2,094,257 -- 245,620 -- 1,937,120 Paul D. Aubert 2,127,552 -- 212,325 -- 1,937,120 Aline Sherwood 2,173,586 -- 166,291 -- 1,937,120 Douglas P. Morris 2,166,978 -- 172,899 -- 1,937,120

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-PATH HOLDINGS, INC. shareholders approved Approval of the 2022 Plan.

Proposal: equity plan
Outcome: passed

Exact text from the filing

Proposal 2 : For the approval of the 2022 Plan: Shares Voted “For” Shares Voted “Against” Shares Abstained Broker Non- Votes 1,996,284 280,998 62,595 1,937,120

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-PATH HOLDINGS, INC. shareholders approved Ratification and approval of the appointment of Ernst & Young, LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2022 at the 2022-12-31 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2022-12-31

Exact text from the filing

Proposal 4 : For the ratification and approval of the appointment of Ernst & Young, LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2022: Shares Voted “For” Shares Voted “Against” Shares Abstained Broker Non- Votes 3,920,967 300,923 55,107 0

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BIO-PATH HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-128653

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.